The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Counterregulatory Actions of Angiotensin-(1-7)
Abstract
Abstract Angiotensin (Ang)-(1-7) is a bioactive component of the renin-angiotensin system that is formed endogenously from either Ang I or Ang II. The first actions described for Ang-(1-7) indicated that the peptide mimicked some of the effects of Ang II, including the release of prostanoids and vasopressin. However, Ang-(1-7) is devoid of vasoconstrictor, central pressor, or thirst-stimulating actions. In fact, new findings reveal depressor, vasodilator, and antihypertensive actions that may be more apparent in hypertensive animals or humans. Thus, the accumulating evidence suggests that Ang-(1-7) may oppose the actions of Ang II either directly or by stimulation of prostaglandins and nitric oxide. These observations are significant because they may explain the effective antihypertensive action of converting enzyme inhibitors in a variety of non–renin-dependent models of experimental and genetic hypertension as well as most forms of human hypertension. In this context, studies in humans and animals showed that the antihypertensive action of converting enzyme inhibitors correlated with increases in plasma levels of Ang-(1-7). In this review, we summarize our knowledge of the mechanisms accounting for the counterregulatory actions of Ang-(1-7) and elaborate on the emerging concept that Ang-(1-7) functions as an antihypertensive peptide within the cascade of the renin-angiotensin system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-(1-7) Dilates Canine Coronary Arteries Through Kinins and Nitric Oxide
Brosnihan, K. B., Li, P., & Ferrario, C. M. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.523 · Cited by 404
Self-citationEffects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell, D. J., Kladis, A., & Duncan, A. M. (1994) · Hypertension · doi:10.1161/01.hyp.23.4.439 · Cited by 317
Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell Growth
Freeman, E. J., Chisolm, G. M., Ferrario, C. M., & Tallant, E. A. (1996) · Hypertension · doi:10.1161/01.hyp.28.1.104 · Cited by 295
Self-citationSchiavone, M. T., Santos, R. A., Brosnihan, K. B., Khosla, M. C., & Ferrario, C. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4095 · Cited by 288
Self-citationSantos, R. A. S., Campagnole-Santos, M. J., Baracho, N. C. V., Fontes, M. A. P., Silva, L. C. S., Neves, L. A. A., R. Oliveira, D., Caligiorne, S. M., Rodrigues, A. R. V., Gropen, C., et al. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90104-x · Cited by 286
Angiotensin actions in the kidney: Renewed insight into the old hormone
Ichikawa, I., & Harris, R. C. (1991) · Kidney International · doi:10.1038/ki.1991.249 · Cited by 284
Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor
Swanson, G. N., Hanesworth, J. M., Sardinia, M. F., Coleman, J. K. M., Wright, J. W., Hall, K. L., Miller-Wing, A. V., Stobb, J. W., Cook, V. I., Harding, E. C., et al. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90527-2 · Cited by 268
Welches, W. R., Bridget Brosnihan, K., & Ferrario, C. M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90108-f · Cited by 254
Self-citationLi, P., Chappell, M. C., Ferrario, C. M., & Brosnihan, K. B. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.394 · Cited by 246
Self-citationDifferential regulation of angiotensin peptide levels in plasma and kidney of the rat.
Campbell, D. J., Lawrence, A. C., Towrie, A., Kladis, A., & Valentijn, A. J. (1991) · Hypertension · doi:10.1161/01.hyp.18.6.763 · Cited by 242
Pörsti, I., Bara, A. T., Busse, R., & Hecker, M. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14787.x · Cited by 239
Luque, M., Martin, P., Martell, N., Fernandez, C., Brosnihan, K. B., & Ferrario, C. M. (1996) · Journal of Hypertension · doi:10.1097/00004872-199606000-00017 · Cited by 230
Self-citationAntihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats
Benter, I. F., Ferrario, C. M., Morris, M., & Diz, D. I. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.1.h313 · Cited by 225
Self-citationCardiovascular actions of angiotensin(1–7)
Benter, I. F., Diz, D. I., & Ferrario, C. M. (1993) · Peptides · doi:10.1016/0196-9781(93)90097-z · Cited by 201
Self-citationAngiotensin-(1-7): a new hormone of the angiotensin system.
Ferrario, C. M., Brosnihan, K. B., Diz, D. I., Jaiswal, N., Khosla, M. C., Milsted, A., & Tallant, E. A. (1991) · Hypertension · doi:10.1161/01.hyp.18.5_suppl.iii126 · Cited by 182
Self-citationCardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats
Campagnole-Santos, M. J., Diz, D. I., Santos, R. A., Khosla, M. C., Brosnihan, K. B., & Ferrario, C. M. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.1.h324 · Cited by 171
Self-citationRenal actions of angiotensin-(1-7): in vivo and in vitro studies
Handa, R. K., Ferrario, C. M., & Strandhoy, J. W. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.1.f141 · Cited by 169
Self-citationAngiotensin-(1-7) Potentiates the Hypotensive Effect of Bradykinin in Conscious Rats
Paula, R. D., Lima, C. V., Khosla, M. C., & Santos, R. A. S. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.1154 · Cited by 160
Differential baroreceptor reflex modulation by centrally infused angiotensin peptides
Campagnole‐Santos, M. J., Heringer, S. B., Batista, E., et al. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.263.1.r89 · Cited by 155
Natriuretic action of angiotensin(1–7)
DelliPizzi, A., Hilchey, S. D., & Quilley, C. P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14014.x · Cited by 154
Angiotensin(1–7) in the spontaneously hypertensive rat
Kohara, K., Brosnihan, K. B., & Ferrario, C. M. (1993) · Peptides · doi:10.1016/0196-9781(93)90063-m · Cited by 152
Self-citationProduction of angiotensin-(1-7) by human vascular endothelium.
Santos, R. A. S., Brosnihan, K. B., Jacobsen, D. W., DiCorleto, P. E., & Ferrario, C. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii56 · Cited by 151
Self-citationDifferential responses to angiotensin-(1–7) in the feline mesenteric and hindquarters vascular beds
Osei, S. Y., Ahima, R. S., Minkes, R. K., Weaver, J. P., Khosla, M. C., & Kadowitz, P. J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90703-k · Cited by 147
Jaiswal, N., Diz, D. I., Chappell, M. C., et al. (1992) · Hypertension · doi:10.1161/01.hyp.19.2_suppl.ii49 · Cited by 132
Self-citationAngiotensin 1-7 has a biphasic effect on fluid absorption in the proximal straight tubule.
Garcia, N. H., & Garvin, J. L. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v541133 · Cited by 115
Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance
Santos, R. A. S., Silva, A. C. S. E., Magaldi, A. J., et al. (1996) · Hypertension · doi:10.1161/01.hyp.27.4.875 · Cited by 110
Angiotensin-(1-7) and Nitric Oxide Interaction in Renovascular Hypertension
Nakamoto, H., Ferrario, C. M., Fuller, S. B., Robaczewski, D. L., Winicov, E., & Dean, R. H. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.796 · Cited by 109
Self-citationAngiotensin-(1-7). A member of circulating angiotensin peptides.
Kohara, K., Brosnihan, K. B., Chappell, M. C., Khosla, M. C., & Ferrario, C. M. (1991) · Hypertension · doi:10.1161/01.hyp.17.2.131 · Cited by 108
Self-citationAngiotensin (1???7) is an antagonist at the type 1 angiotensin II receptor
Mahon, J. M., Carr, R. D., Nicol, A. K., & Henderson, I. W. (1994) · Journal of Hypertension · doi:10.1097/00004872-199412000-00010 · Cited by 106
Evidence that prolyl endopeptidase participates in the processing of brain angiotensin
Welches, W. R., Santos, R. A. S., Chappell, M. C., Brosnihan, K. B., Greene, L. J., & Ferrario, C. M. (1991) · Journal of Hypertension · doi:10.1097/00004872-199107000-00008 · Cited by 105
Self-citationModulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7)
Leyen, S. A., Romero, M. F., Khosla, M. C., et al. (1993) · Kidney International · doi:10.1038/ki.1993.334 · Cited by 101
Moriguchi, A., Tallant, E. A., Matsumura, K., Reilly, T. M., Walton, H. L., Ganten, D., & Ferrario, C. M. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1260 · Cited by 90
Self-citationComparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles.
Meng, W., & Busija, D. W. (1993) · Stroke · doi:10.1161/01.str.24.12.2041 · Cited by 89
Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene
Moriguchi, A., Brosnihan, K. B., Kumagai, H., Ganten, D., & Ferrario, C. M. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.266.4.r1273 · Cited by 89
Self-citationBenter, I. F., Diz, D. I., & Ferrario, C. M. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.1138 · Cited by 79
Self-citationProlylcarboxypeptidase (angiotensinase C) in human lung and cultured cells.
Kumamoto, K., Stewart, T. A., Johnson, A., & Erdös, E. G. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110015 · Cited by 77
Jaiswal, N., Tallant, E. A., Jaiswal, R. K., Diz, D. I., & Ferrario, C. M. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38196-6 · Cited by 74
Self-citationHilchey, S. D., & Quilley, C. P. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1238 · Cited by 69
Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells
Jaiswal, N., Diz, D. I., Tallant, E. A., et al. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.260.5.r1000 · Cited by 61
Self-citationAngiotensin-(1-7) is a potent antidiuretic peptide in rats.
Santos, R. A. S., & Baracho, N. C. V. (1992) · PubMed · Cited by 58
Burnier, M., Péchère-Bertschi, A., Nussberger, J., Waeber, B., & Brunner, H. R. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90163-9 · Cited by 47
Pathologic consequences of increased angiotensin II activity
Ferrario, C. M., & Flack, J. M. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00050990 · Cited by 45
Self-citationFreeman, E. J., Ferrario, C. M., & Tallant, E. A. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00221-a · Cited by 21
Self-citationA new myocardial conversion of angiotensin I
Ferrario, C. M., & Chappell, M. C. (1994) · Current Opinion in Cardiology · doi:10.1097/00001573-199409000-00004 · Cited by 20
Self-citationSzigethy, E. M., Barnes, K. L., & Diz, D. I. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90149-r · Cited by 19
Self-citation
Cited by
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Self-citationHydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
RICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M. (2004) · Biochemical Journal · doi:10.1042/bj20040634 · Cited by 619
Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B., & Ferrario, C. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000124667.34652.1a · Cited by 564
Self-citation
Metadata
- Authors
- Ferrario, C. M., Chappell, M. C., Tallant, E. A., Brosnihan, K. B., & Diz, D. I.
- Venue
- Hypertension
- Published
- 1997-09
- Volume
- 30
- Issue
- 3
- Pages
- 535-541
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W1970068637
- Cited by
- 509
- References
- 45
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.